![](/img/cover-not-exists.png)
220 Cost per response for abatacept versus adalimumab in patients with seropositive erosive, early rheumatoid arthritis in the United States, Germany, Spain and Canada
Foo, Jason, Rodríguez-Heredia, José M R, Polanco Sánchez, Carlos, Mtibaa, Mondher, Herrmann, Kirsten H, Alemao, Evo, Postema, Roelien, Baerwald, ChristophVolume:
57
Language:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/key075.444
Date:
April, 2018
File:
PDF, 67 KB
english, 2018